NSE filing, NSE: KRITI. Summary written from the filing by ALFA Finder's alert engine.
Kriti Industries (India) Ltd: key numbers
- Share price
- ₹50.29
- Market cap
- ₹265.0 Cr
- Revenue (annual)
- ₹587.4 Cr
- Net profit (annual)
- ₹1.13 Cr
- P/E (TTM)
- -31.8×Sector 52.2×
- Promoter holding
- 69.07%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kriti Industries (India) Ltd
All →Kriti Industries (India) Other Announcement
This is a periodic Shareholding Pattern filing pursuant to SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Kriti Industries (India) Management Change
CS Aditi Randhar has resigned from her position as Company Secretary, Compliance Officer, and Key Managerial Personnel of Kriti Industries (India) Limited, effective September 21, 2026.
Kriti Industries (India) Annual General Meeting
Kriti Industries (India) filed the minutes of its 36th AGM held August 12, 2026. The meeting ran via OAVM and closed at 3:47 P.M.
Kriti Industries (India) Annual General Meeting
Kriti Industries (India) Limited held its 36th Annual General Meeting on August 12, 2026, via video conferencing. The meeting covered standard business resolutions including adoption of financial statements.
Kriti Industries (India) Management Change
Kriti Industries (India) Limited has appointed Shri Pradeep Shastri Vedula as Chief Executive Officer effective August 11, 2026. He brings over 20 years of leadership experience.
Kriti Industries (India) Q1 FY27 Results: Net Loss of ₹2.2 Cr
Kriti Industries (India) Ltd reported revenue from operations of ₹173.1 Cr (-22.8% YoY) and a net loss of ₹2.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹2.2 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.